Precipio, Inc.

Healthcare · Diagnostics & Research · United States

Last price 19.35 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 34.64M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.